Rare diseases
Investigational molecules
Locations
Back to Germany390 clinical trials in Erlangen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
GermanyA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
GermanyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
GermanyA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
GermanyA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
GermanyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
GermanyA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
GermanyA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of new therapies for HR-positive and HER2-negative variants. Additional research encompasses lung cancer and various lymphomas.
Studies evaluate novel therapeutic combinations and targeted treatments for improved patient outcomes.
Comprehensive research into various autoimmune disorders, including lupus erythematosus, psoriasis, and systemic conditions. Studies focus on innovative therapeutic approaches.
Trials aim to develop more effective treatments for chronic autoimmune conditions.
Clinical investigations focusing on acute cerebral ischemic stroke and multiple system atrophy. Research emphasizes innovative therapeutic approaches for better patient outcomes.
Studies evaluate new therapeutic agents and treatment strategies for neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
